RSP Systems secures new funding towards noninvasive glucose monitor
RSP Systems (Odense, Denmark), which focuses on using Raman spectroscopy for noninvasive glucose monitoring, has completed the first closing of a Series B funding round amounting to €6.5 million (approx. $7.6 million). The round remains open for a second closing because of strong interest.
Related: RSP Systems receives $2.6M grant for Raman spectroscopy-enabled device to monitor glucose
The proceeds of this round will be used to fund more extensive clinical trials, allowing the company to prepare for regulatory approval and market launch of a glucose monitoring device for diabetes management. To date, the company has raised a total of €19.5 million (approx. $22.9 million), including the Horizon 2020 grant awarded by the EU in 2016.
For more information, please visit www.rspsystems.com.
BioOptics World Editors
We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)